First Allied Advisory Services’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-21,950
Closed -$531K 1188
2020
Q2
$531K Hold
21,950
0.02% 636
2020
Q1
$384K Hold
21,950
0.02% 678
2019
Q4
$380K Buy
21,950
+3,000
+16% +$51.9K 0.01% 818
2019
Q3
$292K Buy
+18,950
New +$292K 0.01% 907